Jeffrey G. Smith
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Pfizer (United States)(US)Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Cervical Cancer and HPV Research, Antifungal resistance and susceptibility, Reproductive tract infections research, Poxvirus research and outbreaks
Most-Cited Works
- → Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene(2003)398 cited
- → Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine(2008)351 cited
- → Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine(2003)318 cited
- → In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)(1997)312 cited
- → Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine(2009)268 cited
- → Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis